366 related articles for article (PubMed ID: 10336527)
1. Sigma1 recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure.
Bucolo C; Campana G; Di Toro R; Cacciaguerra S; Spampinato S
J Pharmacol Exp Ther; 1999 Jun; 289(3):1362-9. PubMed ID: 10336527
[TBL] [Abstract][Full Text] [Related]
2. Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites.
Campana G; Bucolo C; Murari G; Spampinato S
J Pharmacol Exp Ther; 2002 Dec; 303(3):1086-94. PubMed ID: 12438531
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
[TBL] [Abstract][Full Text] [Related]
5. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
6. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
7. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
Chaki S; Tanaka M; Muramatsu M; Otomo S
Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
[TBL] [Abstract][Full Text] [Related]
8. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
Ogidigben M; Chu TC; Potter DE
J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
[TBL] [Abstract][Full Text] [Related]
9. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
Moore TT; Potter DE
Exp Eye Res; 2001 Aug; 73(2):167-78. PubMed ID: 11446767
[TBL] [Abstract][Full Text] [Related]
10. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
Halberstadt AL; Hyun J; Ruderman MA; Powell SB
Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
[TBL] [Abstract][Full Text] [Related]
11. Discrepancies in characterization of sigma sites in the mouse central nervous system.
Kovács KJ; Larson AA
Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
[TBL] [Abstract][Full Text] [Related]
12. Differences in the allosteric modulation by phenytoin of the binding properties of the sigma1 ligands [3H](+)-pentazocine and [3H]NE-100.
Cobos EJ; Lucena G; Baeyens JM; Del Pozo E
Synapse; 2006 Mar; 59(3):152-61. PubMed ID: 16342057
[TBL] [Abstract][Full Text] [Related]
13. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
Ucar H; Cacciaguerra S; Spampinato S; Van derpoorten K; Isa M; Kanyonyo M; Poupaert JH
Eur J Pharmacol; 1997 Sep; 335(2-3):267-73. PubMed ID: 9369382
[TBL] [Abstract][Full Text] [Related]
14. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
Mittag TW; Tormay A; Messenger M; Podos SM
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits.
Chidlow G; Nash MS; De Santis LM; Osborne NN
Exp Eye Res; 1999 Dec; 69(6):587-93. PubMed ID: 10620387
[TBL] [Abstract][Full Text] [Related]
16. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes.
Bouchard P; Quirion R
Neuroscience; 1997 Jan; 76(2):467-77. PubMed ID: 9015331
[TBL] [Abstract][Full Text] [Related]
17. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
[TBL] [Abstract][Full Text] [Related]
18. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
Torrence-Campbell C; Bowen WD
Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
[TBL] [Abstract][Full Text] [Related]
19. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
Matsumoto RR; Bowen WD; de Costa BR; Houk JC
Brain Res Bull; 1999 Mar; 48(5):497-508. PubMed ID: 10372510
[TBL] [Abstract][Full Text] [Related]
20. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
